Literature DB >> 16209441

Corneal keratocyte apoptosis following topical intraoperative mitomycin C in rabbits.

Shu-Wen Chang1.   

Abstract

PURPOSE: To determine the soaking duration and concentration effect of mitomycin C (MMC) on the corneal keratocyte following single intraoperative application.
METHODS: Two hundred ten pigmented rabbit eyes underwent mechanical epithelium debridement of the central 10-mm comea followed by soaking of six different solutions: MMC1A: 0.01% MMC x 1 minute; MMC1B: 0.01% MMC x 2 minutes; MMC2A: 0.02% MMC x 1 minute; MMC2B: 0.02% MMC x 2 minutes; BSS1: balanced salt solution (BSS) x 1 minute; and BSS2: BSS x 2 minutes. Thirty-five eyes were allocated into each group. Changes of the central comeal thickness, corneal clarity score, and keratocyte apoptosis were examined on days 0, 1, 2, 3, 5, 7, and 14.
RESULTS: A significant increase of central corneal thickness and corneal clarity score was noted in all MMC treated groups. The central corneal thickness recovered to its baseline level whereas the corneal clarity score remained increased at 2 weeks. The changes were more significant in MMC2 than in MMC1 corneas. However, changes of central corneal thickness and corneal clarity score were more significant in MMC1B than in MMC1A, whereas no difference was noted between MMC2A and MMC2B. Significantly higher stromal keratocyte loss and keratocyte apoptosis, from superficial to deep corneal stroma, was noted in MMC1 and MMC2 groups up to 14 days postoperatively, in a soaking duration and dose-dependent manner.
CONCLUSIONS: Single application of MMC on the corneal surface caused soaking concentration and duration dependent corneal edema and keratocyte apoptosis in this rabbit model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209441     DOI: 10.3928/1081-597X-20050901-05

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  8 in total

1.  Mitomycin C: a promising agent for the treatment of canine corneal scarring.

Authors:  Rangan Gupta; Benjamin W Yarnall; Elizabeth A Giuliano; Jagat R Kanwar; Dylan G Buss; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2011-04-18       Impact factor: 1.644

2.  Moxifloxacin modifies corneal fibroblast-to-myofibroblast differentiation.

Authors:  T C Chen; S W Chang; T Y Wang
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

3.  The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina.

Authors:  Matthias Lüke; Kai Januschowski; Julia Lüke; Salvatore Grisanti; Peter Szurman; Klaus Dietz; Anselm Kampik; Karl Ulrich Bartz-Schmidt; Kirsten H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-20       Impact factor: 3.117

4.  DNA cross-linking, double-strand breaks, and apoptosis in corneal endothelial cells after a single exposure to mitomycin C.

Authors:  Danny S Roh; Amanda L Cook; Steven S Rhee; Amar Joshi; Regis Kowalski; Deepinder K Dhaliwal; James L Funderburgh
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-24       Impact factor: 4.799

Review 5.  The corneal fibrosis response to epithelial-stromal injury.

Authors:  Andre A M Torricelli; Abirami Santhanam; Jiahui Wu; Vivek Singh; Steven E Wilson
Journal:  Exp Eye Res       Date:  2016-01       Impact factor: 3.467

6.  Quiescent keratocytes fail to repair MMC induced DNA damage leading to the long-term inhibition of myofibroblast differentiation and wound healing.

Authors:  James V Jester; Chyong Jy Nien; Vasilis Vasiliou; Donald J Brown
Journal:  Mol Vis       Date:  2012-07-04       Impact factor: 2.367

7.  Mechanism of mitomycin-induced apoptosis in cultured corneal endothelial cells.

Authors:  Kwou-Yeung Wu; Hwei-Zu Wang; Show-Jen Hong
Journal:  Mol Vis       Date:  2008-09-15       Impact factor: 2.367

Review 8.  A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery.

Authors:  Esther Arranz-Marquez; Andreas Katsanos; Vassilios P Kozobolis; Anastasios G P Konstas; Miguel A Teus
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.